Sanofi-Aventis Warns Of Norpramin Heart Attack Risk
Sanofi-Aventis SA has sent a warning to doctors that they should be careful when prescribing the company's antidepressant Norpramin, saying it can cause sudden, fatal heart attacks in patients with irregular...To view the full article, register now.
Already a subscriber? Click here to view full article